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Abstract 
 
 
Peri-implant disease is a collective term for inflammatory lesions involving the implant 
supporting periodontal tissues which if not diagnosed early can progress to loss of osseo-
integration and late implant failure (Heitz-Mayfield, 2008: 292). Peri-implant disease 
encompasses peri-implant mucositis and peri-implantitis. Peri-implant mucositis is a 
reversible inflammatory lesion only affecting the soft tissue around an implant, similar to 
gingivitis around the natural dentition. If the pathological condition is left untreated 
progression to peri-implantitis may occur (Heasman et al, 2010:511; Grusovin et al, 2010: 3). 
The increasing amount of patients treated with implant-restored fixtures may contribute to 
a higher incidence of peri-implant infections (Renvert and Persson, 2009: 9), especially in 
the absence of a supportive maintenance care programme. Early identification of the signs 
and symptoms of peri-implant disease are crucial in preventing further disease progression 
(Karbach et al, 2009: 492). When reviewing the literature it is apparent that this is a large 
scale problem among implant restored patients. Prevalence rates of peri-implant mucositis 
are high affecting roughly 50% of implant sites and 80% of patients (Lindhe and Meyle, 
2008: 284; Heasman et al, 2010: 512). Aim: To determine the prevalence of peri-implant 
mucositis and the association between systemic and local risk factors. Method: An analytical 
cross-sectional study was carried on 74 patients with restored single implants treated at the 
Oral Medicine and Periodontology (OMEDP) Department of the Faculty of Dentistry of the 
University of the Western Cape, in the period 1st January 2005 until end October 2011. The 
various risk factors for peri-implant disease that were evaluated included gender, smoking, 
diabetes, implant position in dental arch, implant connection, implant diameter, type of 
implant restored crown, keratinized gingival width, and oral hygiene. Peri-implant mucositis 
around implants was evaluated by visual examination as measured by bleeding on probing 
(BOP) in the peri-implant sulcus. A positive response to bleeding on probing (BOP) was 
considered a positive sign for the presence of peri-implant mucositis using a Vivacare TPS® 
periodontal probe.  Data was transferred onto a Microsoft Excel® spread sheet and analysed 
using the Microsoft Excel® program. The prevalence of peri-implant mucositis in the sample 
population and the null hypothesis was tested with a statistical test, the chi-squared test for 
not normally distributed data. Results: There was an overall prevalence of peri-implant 
mucositis in the study population of 70.3% per implant site. The null hypothesis was 
rejected by four risk factors which had a statistically significant association with peri-implant 
mucositis: anterior dental arch position; wider keratinized gingival widths; poor to fair oral 
hygiene status; and prior oral hygiene instructions. Analysis of the data revealed that the 
majority (77.27%) of implant-supported cement retained restorations in the anterior area 
presented with bleeding on probing. This may be explained by the extrusion of cement 
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around the margins of a cement-retained restoration which, given time in a vascular 
environment of peri-implant gingiva could elicit a foreign body inflammatory reaction. 
Conclusion and recommendations: The high prevalence rate obtained from the study 
population highlights the need for implant maintenance in general. To ensure optimal long 
term mucosal health around dental implants caution needs to be exercised when planning 
cement-retained restorations. Further research is necessary on the various risk factors 
associated with the onset of peri-implant disease, however a larger sample size is 
recommended.  
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CHAPTER 1: 
INTRODUCTION 
 
 
1.1. Structure of the report 
 
This mini-thesis consists of seven chapters relating to the various aspects investigated in this 
analytical cross-sectional study. 
 
Chapter 1 summarizes the background and purpose of the study. Chapter 2 provides a 
comprehensive literature review and includes recent definitions, prevalence rates and 
criteria for the diagnosis of peri-implant disease. It concludes with a list of the various 
systemic and local risk factors associated with peri-implant disease. 
 
Chapter 3 describes the study aim, objectives and null hypothesis. Chapter 4 describes the 
research design and methodology. It elaborates on the research tool, data collection 
procedures and instruments used. It elucidates on the calibration of the researcher, data 
management and analysis as well as ethical considerations.  
 
Chapters 5 to 7 detail the results, discussion, conclusion and recommendations respectively. 
 
1.2. Background and purpose of the study 
 
The increasing amount of patients treated with implant-supported prosthesis may 
contribute to a higher incidence of peri-implant infections (Renvert and Persson, 2009: 9). 
Early identification of the signs and symptoms of peri-implant disease are crucial in 
preventing further disease progression (Karbach et al, 2009: 492).  
 
When reviewing the literature, it is apparent that peri-implant infections are a large scale 
problem among patients restored with implant prosthesis. Most of the literature reporting 
on the prevalence rates of peri-implant disease originates from international studies and to 
date, this is the first South African prevalence study to report on the prevalence of peri-
implant disease. The prevalence of peri-implant mucositis is reported to range between 
30.7% - 50% of implant sites and 63.4% - 80% of patients (Lindhe and Meyle, 2008: 284; 
Heasman et al, 2010: 512; Atieh et al, 2012). Atieh et al, 2012, found this to occur with or 
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without any supportive periodontal maintenance care. Rinke et al (2011) evaluated the 
frequency of peri-implantitis and found that implant patients not enrolled in a supportive 
maintenance care program had an 11 fold greater risk for developing peri-implant disease. 
 
The rationale for this research project is to determine the prevalence rate of peri-implant 
mucositis and the relationship between various risk factors among patients with restored 
single implants at the Oral Medicine and Periodontology Department (OMEDP) of the 
Faculty of Dentistry of the University of the Western Cape (UWC). 
 
The study population comprised of patients with single implants placed at the OMEDP and 
restored at the UWC Prosthetic Department, during the period 01 January 2005 to end of 
October 2011 (a period of 6 years and 10 months). 
 
To date, neither stringent follow-up protocols, nor maintenance programs are employed at 
the OMEDP. As previously mentioned, the risk of developing peri-implant disease is 
increased if patients do not participate in a regular maintenance program. Peri-implant 
disease is difficult and costly to manage and if left untreated, will result in late implant 
failure. The initiation of a maintenance program will prove to be beneficial for these 
patients.  
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CHAPTER 2: 
LITERATURE REVIEW 
 
 
2.1.  Background: 
 
Peri-implant disease encompasses inflammatory changes within the periodontal tissues 
surrounding an implant. Loss of osseo-integration and late implant failure can follow if not 
diagnosed and treated early (Heitz-Mayfield, 2008: 292).  
  
Dental implants are at risk of bacterial colonization as the micro flora found are similar to 
that of the adjacent teeth and are formed within the first week of implant insertion. 
Periodontal pathogens are similar in peri-implant disease but differ from those found 
around teeth with a healthy dentogingival unit. These periodontal pathogens are present in 
the peri-implant micro flora within the first two weeks after implant exposure. It was 
proposed that the natural dentition acts as a bacterial reservoir for the colonization of 
implants (Thὃne-Mühling et al, 2010: 506; Greenstein et al, 2010: 116).  
 
The surface characteristics of the implant directly affect the amount of bacteria attaching on 
the surface of the implant when the implant is exposed. Rougher implants promotes more 
surface adherence of bacteria. Rough implant surfaces are very difficult to clean and are 
often repopulated by the regrowth of the residual biofilm of bacteria, after their rough 
surfaces have been cleaned (Khammissa et al, 2012: 72).  
 
The formation of an adherent layer of plaque on the implant appears to be vital in the 
formation of peri-implant diseases and could be the reason for the change in the 
biocompatibility of implant surfaces. Gram-negative anaerobic bacteria are primarily linked 
with peri-implant diseases (Renvert et al, 2008: 309). A large quantity of recognized 
periodontal pathogens such as Porphyramonas gingivalis, Prevotella intermedia, Treponema 
denticola, Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum, has 
been related with the onset of peri-implant disease. Staphylococcus aureus may also be 
associated with peri-implant disease as titanium surfaces favour their attachment 
(Shumaker et al, 2009: 392; Khammissa et al, 2012: 72). As a result, peri-implant infections 
are caused by a disproportion between bacterial load and host defence (Heitz-Mayfield, 
2008: 292). 
 
When the healing or prosthetic abutment is attached to the implant body, bacteria become 
imprisoned within the microgap (of various dimensions) at the implant-abutment interface. 
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The microgap is a source of contamination and therefore results in inflammation in the peri-
implant marginal soft tissue unit (Khammissa et al, 2012: 72). 
 
2.2.  Definitions and terms: 
 
Peri-implant disease can be divided into peri-implant mucositis and peri-implantitis. Peri-
implant mucositis is a reversible inflammatory lesion restricted to the soft tissues around an 
implant. It is similar to gingivitis around the natural dentition. If left untreated, progression 
to peri-implantitis may ensue (Heasman et al, 2010:511; Grusovin et al, 2010: 3; Khammissa 
et al, 2012: 70). Peri-implantitis is an inflammatory condition of the gingiva around the 
implant which spreads apically and may result in the progressive destruction of the osseo-
integrated bone, increased probing depth with exudation (Karbach et al, 2009: 492; 
Shumaker et al, 2009: 392). This bone loss can result in the failure of the implant (Nogueira-
Filho et al, 2010: 1). 
 
2.3.  Prevalence of peri-implant disease: 
 
There is inconsistent data in the literature regarding the prevalence of peri-implant disease. 
This may be due to the different clinical criteria used to evaluate and define the disease or 
the different observation periods in the previous international studies or different surface 
enhancements (Ferreira et al, 2006: 932; Atieh et al, 2012: 3).  
 
There is a paucity of the cross-sectional studies reporting on the prevalence of peri-implant 
infections. Some studies show that peri-implant mucositis affects roughly 50% of implant 
sites and 80% of patients, however peri-implantitis affects roughly 12 – 43% of implant sites 
and 28 -56% of patients (Lindhe and Meyle, 2008: 284; Heasman et al, 2010: 512; 
Khammissa et al, 2012: 70). However, Atieh et al (2012: 1 -12), in a recent systematic 
review, found the prevalence of peri-implant mucositis and peri-implantitis to be 63.4% of 
participants; 30.7% of implants and 18.8% of patients; 9.6% of implants respectively. These 
findings were independent of patient follow-up. 
 
This high prevalence rate of peri-implant disease emphasises the need for maintenance care 
(Heasman et al, 2010: 512; Atieh et al, 2012: 1, 8). If peri-implant disease is left untreated 
the condition may cause implant failure (Heitz-Mayfield, 2008: 292). Implant failure can 
occur during the early (less than 6 weeks) or late (after 3 months) healing period after 
implant placement. However, the primary reason for late implant failures (after 3 months of 
placement) is peri-implant infections (Karbach et al, 2009: 491; Chen and Darby, 2003: 212). 
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2.4.  Diagnosis of disease: 
 
The diagnosis of peri-implant mucositis is achieved by using both visual and tactile 
examination of the peri-implant marginal soft tissue. Under healthy conditions the soft 
tissue layer directly next to the implant is less vascular, less cellular, and has an increased 
amount of collagen scar tissue when compared to normal gingival tissue. 
 
With peri-implant mucositis the peri-implant marginal soft tissues appears erythematous 
(Lindhe and Meyle, 2008: 284; Heasman et al, 2010: 512) with the presence of bleeding on 
probing and or suppuration (Figure 1). Bleeding on probing is a sign of inflammation in the 
peri-implant sulcus and the absence thereof is indicative of peri-implant health (Chen and 
Darby, 2003:214). Histologically, peri-implant mucositis resembles gingivitis. After the 
bacterial biofilm accumulates, the inflammatory cell infiltrate in the peri-implant soft tissue 
are similar to that seen in the dentogingival unit in gingivitis (Khammissa et al, 2012: 124). 
 
 
 
Figure 1: Peri-implant mucositis: Erythematous marginal soft tissue around 14 which 
bled after probing. 
 
The clinical picture of peri-implantitis is associated with peri-implant marginal soft tissue 
erythema, probing depths of more than 5mm and bleeding on probing, suppuration and 
radiographic evidence of marginal bone loss - more than 0.2 mm annually or progressively 
(Figure 2). Sites with peri-implantitis show the presence of plaque and histological 
evaluation of the inflammatory infiltrate in the connective tissue around the implants 
includes macrophages, lymphocytes, plasma cells and several neutrophil granulocytes 
(Lindhe and Meyle, 2008: 284; Atieh et al, 2012: 3).   
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A      B   
 
Figure 2: Peri-implantitis: The 12 implant presents with an erythematous peri-
implant marginal soft tissue, recession and suppuration (A); as well as loss 
of osseo-integrated marginal bone (B) seen on the peri-apical radiograph. 
 
2.5.  Risk factors associated with peri-implant disease: 
 
Risk factors are defined as the various factors reported to be associated with the 
development of peri-implant disease and also referred to as risk variables (Lindhe and 
Meyle, 2008: 284). When treating patients with peri-implant disease, early recognition of 
associated risk factors is essential even before initiating treatment. In so doing, these 
causative factors may be addressed to improve the prognosis of the treatment (Karbach et 
al, 2009: 491; Nogueira-Filho et al, 2010: 5).   
 
1. Bacterial plaque 
 
The composition of bacterial plaque on dental implants is similar to the microbiology of the 
natural dentition (Chen and Darby, 2003: 212). Soft tissue around dental implants react to 
the bacterial plaque accumulation and inflammatory lesions will develop as a result in the 
peri-implant soft tissue (Grusovin et al, 2010: 3). It has been shown (Ferreira et al in 2006) 
that subjects with poor oral hygiene and an increased plaque accumulation have a higher 
association with peri-implant disease. Furthermore, the implant site accessibility for oral 
hygiene can influence the presence of peri-implant disease (Serino and Strὃm, 2009: 170). 
Poor oral hygiene is therefore an risk factor for peri-implant disease. 
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2. Keratinized gingival width 
 
Conflicting evidence has been reported on the effect of keratinized gingival width and peri-
implant health. Numerous studies (sited in Greenstein et al, 2010: 115) reported peri-
implant mucositis in patients with a lack of keratinized gingiva. Similarly other studies (sited 
in Greenstein et al, 2010: 115) maintained the contrary. This may be explained by the 
observation that with proper oral hygiene, peri-implant health can be preserved regardless 
of the extent of keratinized gingival tissue around the implant. However, if there is meagre 
oral hygiene in the oral cavity, sufficient amount of keratinized gingiva may prove valuable 
(Greenstein et al, 2010: 115). All of these studies did not elaborate on the effect that muscle 
pull had on the amount of keratinized gingival width and peri-implant health. 
 
3. Periodontally compromised patients 
 
Patients who lose teeth due to periodontal disease are also managed with dental implant 
fixtures (Heitz-Mayfield, 2008: 296). Several studies have looked at the association between 
periodontally compromised patients and peri-implant infections. A periodontally 
compromised patient is defined as a subject with a history of either chronic or aggressive 
periodontitis but without active disease at the time of implant placement. These patients 
had undergone periodontal therapy (i.e. non-surgical or surgical) before implant placement.  
 
The systematic review of Karoussis et al (2007) investigated 15 prospective studies and 
examined the implant survival rates in periodontally compromised subjects and compared 
the short-term and long-term studies as well as subjects with chronic and aggressive 
periodontitis with each other. The short-term studies were conducted over a period of less 
than 5 years while the long-term studies were conducted over a period of 5 years or more. 
The short-term studies stressed a stringent individual maintenance programme after 
implant placement. Longer-term studies showed an increase in probing depths, peri-implant 
bone loss and incidence of peri-implantitis. They concluded that in long-term follow-up 
studies, subjects with a history of chronic periodontal disease were at an increased risk for 
the development of peri-implantitis, however further research is necessary as evidence is 
limited and confounding factors in these long-term studies such as diabetes and smoking in 
patients with periodontal disease makes it difficult to determine the effects of periodontitis 
history alone. Their second conclusion was that short-term studies in subjects with chronic 
periodontal disease had an implant survival rate similar to periodontally healthy individuals; 
however these subjects were placed under an individual maintenance care programme 
subsequent to implant placement. Studies on implants placed in patients with a history of 
aggressive periodontitis are restricted to short-term follow-up, with favourable survival 
rates. Long term results are however not available. 
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In a retrospective study (Rinke et al, 2011: 828) the frequency of peri-implantitis amongst 
participants with a history of periodontal disease was comparable to those without. In this 
retrospective study was found that regular maintenance proved favourable in maintaining 
peri-implant health and that the lack thereof resulted in an eleven fold increase in the risk of 
peri-implant disease.  
 
4. Uncontrolled Diabetes Mellitus 
 
Diabetes mellitus is a chronic metabolic disorder that occurs when the glucose in the blood 
cannot be absorbed into the cells of the body. This occurs when the pancreas fails to 
produce sufficient amount of insulin or the cells discontinue responding to the insulin that is 
produced. Uncontrolled diabetes is considered a risk variable for implant failure and a 
contraindication for implant therapy. Chronic hyperglycaemia results in chronic 
inflammation which can lead to bone resorption. Furthermore, diabetics are at a higher risk 
for infection due to being in an immune-suppressed state, which results in delayed wound 
healing. Local infection post-surgically and the inability to protect against infection in these 
patients may play a role in implant complications seen in these patients (Zupnik et al, 2011: 
4; Heitz-Mayfield, 2008: 296). In a study done by Ferreira et al (2006) subjects were 
considered diabetics if they had an individual fasting blood sugar of ≥ 126 mg/dl or had been 
using anti-diabetic drugs for the past two weeks. They concluded that poor metabolic 
control in diabetics was associated with a higher risk for peri-implantitis. 
 
5. Smoking 
Smoking has a profound effect on the periodontium with regards to implant patients’ 
wound healing. The mechanism by which smoking influences wound healing can be divided 
into four categories (Liddelow and Klineberg, 2011: 422): 
a) The carbon monoxide produced by the cigarette reduces the oxygen levels in 
the blood of the healing tissues; 
b) Nicotine acts as a vasoconstrictor and reduces the blood flow to the wound 
site; 
c) The cytotoxic activity of the fibroblasts and acute inflammatory cells disrupts 
cell repair and defence; 
d) And wound healing is impaired leading to a greater risk for post-operative 
complications. 
Heterogeneity exists with regards to the definition of smoking described in the various 
studies. In a systematic review (Strietzel et al, 2007: 523 - 544) any patient who smoked 
cigarettes was considered a smoker, irrespective of number or frequency. They found 
smokers were at greater risk for peri-implant disease development and subsequent implant 
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failure, when compared to non-smokers. These findings were supported by Rinke et al 
(2011). 
Karbach et al (2009) found smoking to be the key risk variable for the development of peri-
implant mucositis. Furthermore, tobacco smoking negatively influences the outcome of 
preventative and management programmes for peri-implant disease, because smoking 
increases marginal bone loss around implants (Heasman et al, 2010: 512). 
 
6. Restoration type ( cement vs. screw-retained) 
 
Cement-retained implant restorations are a popular prosthetic treatment modality amongst 
clinicians. During placement of the restoration, complete elimination of the excess cement 
from peri-implant soft tissues is extremely difficult. The deeper the sub-gingival margins of 
the implant restoration (especially 2mm or deeper) the more challenging it becomes to 
adequately remove excess cement. Residual cement will act as an irritant to peri-implant 
soft tissues or cause a potential delayed toxic response to the peri-implant tissues. Excess 
cement deposits irritate peri-implant tissues, triggers an inflammatory response and 
therefore shows a strong association with the development of peri-implant disease 
(Linkevicius et al, 2011: 1, 3, 5).  
 
Screw-retained implant restorations have less untoward peri-implant soft tissue reactions as 
no cement is required during placement thereof (Linkevicius et al, 2011: 1, 3, 5). 
 
7. Alcohol 
 
There is a paucity of evidence relating alcohol consumption to peri-implant disease. A study 
by Galindo-Moreno et al (2005) assessed the effect of alcohol and tobacco use on peri-
implant bone resorption. In subjects with a daily alcohol intake of more than 10g, an 
increased risk for peri-implantitis was found. Secondly, they concluded that alcohol 
consumption resulted in greater peri-implant marginal bone loss, when compared to 
tobacco use. 
 
2.6.  Management of peri-implant disease: 
 
Implants, like natural teeth, require regular follow up visits to verify the health of the soft 
and hard tissues as well as the status of the prosthesis. Periodontal health must be re-
established and maintained before implant therapy can proceed. However, even in a 
healthy peri-implant environment, peri-implant supportive care is essential not only to 
improve the long-term survival of implant-restored fixtures but also for the early detection 
of possible peri-implant complications. The goal of peri-implant supportive care is to reduce 
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the amount of plaque and thereby reduce the risk for further disease progression.  To this 
end, patient motivation for proper oral hygiene is crucial (Shumaker et al, 2009: 389; 
Heasman et al, 2010: 515).  In a retrospective follow-up study (Costa et al, 2012), a high 
incidence of peri-implant mucositis was found in patients not following a supportive 
maintenance care programme. 
 
 Most effective therapeutic intervention 
 
Prevention is the most effective treatment modality for peri-implant conditions (Khammissa 
et al, 2012: 122). When peri-implant disease is diagnosed, identification of risk factors is 
vital to devise patient specific treatment regimens (Grusovin et al, 2010: 3; Heasman et al, 
2010: 515).  
 
The long-term success and prognosis of the implant is directly related to maintaining the 
lowest implant bacterial content through good oral hygiene (Feller et al, 2012: 128). This 
was supported by (Atieh et al in 2012) who showed that consistent supportive periodontal 
care reduced the incidence of peri-implantitis with no one management protocol reported 
to be more clinically effective than the other. 
 
 Frequency of intervention 
 
The frequency of peri-implant supportive care is dependent on the individual susceptibility 
of the patient to various risk factors. With reference to the time interlude between 
maintenance visits, a three month interval is recommended for patients with periodontitis 
requiring supportive care, with some requiring additional visits (Greenstein et al, 2010: 120). 
The general guideline is that bleeding on probing can be used to establish the frequency of 
maintenance intervals in susceptible patients. If bleeding on probing occurs in more than 
16% of the sites (implant/ teeth/ teeth and implants), then maintenance intervals should 
decrease by one month, however if bleeding on probing presents at less than 10% of the 
sites, then the frequency of the maintenance intervals may be increased by one month 
(Shumaker et al, 2009: 395 – 396). 
 
2.7.  Future recommendations: 
 
Nogueira-Filho et al (2010) suggested the formulation of a specific prognostic classification 
system to help guide treatment planning for dental implant fixtures. They proposed that it 
be based on the stability of the peri-implant tissues and probability of implant failure. 
However limited information is available and further investigation into a rational systematic 
prognostic classification system for the management of peri-implant infections is necessary. 
 
 
 
 
Page | 11  
 
 
CHAPTER 3: 
AIMS AND OBJECTIVES 
 
 
3.1. Aim 
 
To determine the relationship between the prevalence of peri-implant mucositis and local 
and systemic risk factors associated with single implant supported crowns. 
 
3.2. Objectives 
 
1. To determine the prevalence of peri-implant mucositis as measured by clinical 
examination. 
 
2. To determine the prevalence of systemic risk factors associated with peri-implant 
mucositis including gender, smoking, and diabetes. 
 
3. To evaluate various local implant related risk factors. This includes the position in the 
dental arch; internal or external connection; the association between a standard 
versus a wide diameter; screw- or cement-retained implant restored crowns.  
 
4. To evaluate local risk factors related to periodontal parameters around the implant 
site. This includes bleeding on probing and keratinized gingival width around the 
implant. 
  
5. To determine the relationship between the bacterial plaque and peri-implant 
mucositis through the use of a plaque-index (modified Sillness and Loё, 1964). 
 
3.3.  Null hypothesis 
 
There is no association between the proposed risk factors and the prevalence of peri-
implant mucositis associated with single implant-supported crowns. 
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CHAPTER 4: 
MATERIALS AND METHODS 
 
 
4.1.   Study design 
 
This is an analytical cross-sectional study to determine the relationship between the 
development of peri-implant mucositis and the presence of different risk variables. 
 
The study utilized both a standardized data collection form and an intra-oral examination 
for each patient (Appendix 1, 2, 3, and 4 respectively). 
 
4.2.   Study population  
 
The study sample comprised of patients with restored single implants placed at the OMEDP 
Department and restored at the Prosthetic Department of the Faculty of Dentistry of the 
University of the Western Cape, in the period ranging from the 1st January 2005 up and until 
the end of October 2011. 
 
Patients included in the study: 
 
• Single implants in partially edentulous mouths; 
 
• Implants of all diameters (irrespective of make or brand); 
 
• Bone level implants with an internal or external connection; 
 
• Implants that were restored for a minimum of one year. 
  
Patients excluded in the study: 
  
• Those that underwent any bone or soft tissue grafting procedure at the 
implant site at time of surgical placement; 
 
• Those with immediately placed implants; 
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        Those with splinted implants or implant bridges;  
 
        Those with tissue level implants. 
 
Data for all patients who receiving implants was captured in a record book in the OMEDP 
Department. The data from suitable candidates was captured in Microsoft Excel® spread 
sheet and the latter program was used to select a random sample. Patients were provided 
with a complimentary check-up and oral prophylaxis. 
 
4.3.   Sample size 
 
Cross-sectional studies report the prevalence of peri-implant mucositis to be approximately 
50% of implant sites and amongst 80% of implant patients (Lindhe and Meyle, 2008: 284; 
Heasman et al, 2010: 512). 
 
 
 (n)  = (z2 × SE2)/d2 
 
n = sample size 
Z= Z value (e.g. 1.96 for 95% confidence level) 
SE = standard error (e.g. represents the amount of sampling variability) 
d = desired level of absolute precision (d=10%) 
 
Therefore sample size (n) = (1.96 × SE2)/d2 
SE for percentage peri-implant mucositis = 50 (e.g. if taken a 50% prevalence of peri-implant 
mucositis) 
Sample size (n)  = (1.962 × 502)/102 
   = (3.8416 × 2500)/100 
   = 96. 04 
Require 97 participants for study to fall within 90% confidence interval. 
 
 
As the estimate of peri-implant mucositis in this study was expected to be around 50% or 
even higher, the maximum proportion of 50% was used to estimate the sample size. The 
study sample necessary to reach this estimate with a 95% confidence interval to fall within 
10 % of the estimate was 97. In the event of possible exclusion of patients during the data 
collection phase a sample of 100 patients was to be selected. 
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The list of patients in the record book eligible for the study was 120 patients of whom 100 
were randomly selected using the Microsoft Excel® program. Each patient from the selected 
group of 100 was contacted and provided a complimentary check-up and oral prophylaxes 
at the time of the appointment, however only 74 patients was willing to partake in the 
study. 
 
4.4.   Data collection procedures and instruments 
 
A standardized data collection (Appendix 1) form as well as an intra-oral examination was 
completed for each patient. 
 
 It was used to record information regarding:  
 
1. The patient’s gender and health: 
 
 Smoking:  
Patients who had been smoking tobacco during the implant check-up 
appointment was categorised as smokers. 
 
 Diabetes:  
The presence of diabetes was based on the patient’s report and no 
differentiation was made between type 1 and 2 diabetes. No further 
chemical blood tests were done. 
 
2. Data related to the implant site: 
 
 Position in dental arch:  
The position of the implant in the dental arch was categorised as either 
anterior or posterior. Anterior implants were positioned in the incisors to 
canine area. Posterior implants were positioned in the premolar to molar 
region.  
 
 Implant diameter:  
The diameter of the implant was divided into either standard or wide. 
Standard diameter implants ranged between 3.7mm and 4.2mm. Wide 
diameter implants ranged between 5 mm and 6 mm. 
 
 Type of implant restoration placed:  
The type of implant restored crown used on each implant was categorised as 
either being a screw-retained or cement-retained crown. 
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 Follow-up time from implant placement 
The elapsed time from implant placement to prosthesis placement was 
calculated for each participant and divided into two groups: 1 to 2 years; and 
more than 2 years. 
 
3.  Clinical periodontal parameters for the implant site:  
 
The intra-oral examination recorded by the primary researcher evaluated the clinical 
parameters at the implant site. The clinical parameters at the implant site were measured 
with a Vivacare true pressure-sensitive (TPS)® periodontal probe applied at a light pressure 
of 20 g (see Figure 3). The Vivacare TPS®periodontal probe has a 0.5 mm ball tip with a 
tactile rim to reduce tissue trauma. The tip of the probe is connected to a spring mechanism 
which regulates the pressure extended to the probe tip. The force indicator lines overlap at 
approximately 20 g force. The probe tip has detailed millimetre measurements (Bergenholtz 
et al, 2000: 93 – 94). The clinical parameters recorded around the implant site included 
(Serino and Ström, 2009: 170; Lindhe et al, 2008: 130): 
 
 Keratinized gingival width:  
This was measured with the Vivacare TPS® periodontal probe and the 
amount of keratinized gingiva measured was categorized into three groups: 
less than 1mm; equal to and more than 1mm but less than 2mm; equal to 
and more than 2mm. 
 
 Bleeding on probing (BOP):  
The Vivacare TPS® periodontal probe was passed along the gingival margin 
around the implant and measurements were recorded at 6 sites (mesio-
buccal, mid-buccal, disto-buccal, mesio-palatal/ lingual, mid-palatal/ lingual, 
disto-palatal/ lingual). The peri-implant tissue was subsequently observed for 
30 seconds to determine the presence or absence of bleeding.   
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A     B  
 
C                           D  
 
E                 F  
 
Figure 3: In photograph (A) the disto-buccal sulcus of the 14 implant is measured 
with the Vivacare TPS® probe and bleeding in the same site is observed 
shortly afterwards in photograph (B). In photograph (C) the 21 implant 
disto-buccal sulcus is measured with the Vivacare TPS® probe and bleeding 
is detected in photograph (D) subsequently. The mirrored image captured 
in photograph (E) the mid-palatal peri-implant sulcus of the 11 implant is 
measured with the Vivacare TPS® probe and in photograph (F) bleeding of 
the peri-implant soft tissue is noted soon afterwards. 
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A positive response to bleeding on probing (BOP) in any of the six sites tested around the 
implant was recorded as positive for the presence of peri-implant mucositis. The latter was 
based on the diagnostic criteria for peri-implant mucositis  which is dependent on visual 
evaluation of the peri-implant marginal soft tissue which will appear erythematous, as well 
as bleeding on probing (BOP) (Lindhe and Meyle, 2008: 284; Heasman et al, 2010: 512; Chen 
and Darby, 2003: 214). 
 
 4. Oral hygiene of the patient: 
 
 Oral hygiene status:  
The general oral hygiene of the patient was measured using a plaque index 
(PI) (modified Sillness and Lὃe 1964). It evaluated the extent of soft plaque 
deposits at the vestibular and lingual gingival margin of selected teeth in the 
dentition. The plaque index for the oral cavity was then calculated by 
totalling the two (vestibular and lingual) plaque scores per tooth and then 
adding the plaque scores for each tooth and dividing it by the number of 
teeth examined (Bayne et al, 2006: 837). 
 
Plaque score:  
 
Score 0:   no plaque in gingival margin or tooth; 
Score 1:   plaque only noticed by running probe over tooth surface; 
Score 2:  moderate accumulation of plaque on gingival margin and tooth and plaque 
can be observed by naked eye; 
Score 3:  abundance of plaque on gingival margin and tooth. 
  
Interpretation of the plaque index (PI) (modified Sillness and Lὃe 1964): 
 
PI 0:    excellent 
PI 0.1– 0.9:  good 
PI 1.0– 1.9:   fair 
PI 2.0– 3.0:   poor 
 
 Brushing frequency:  
The brushing frequency for each patient was categorised into:  never, or 
every other day, or twice daily. 
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 Flossing frequency : 
The flossing habit for each patient was divided into the following categories: 
never, or every other day, or twice daily. 
 
 Rinsing with mouthwash: 
It was not established what type of mouthwash each patient was using, only 
the frequency of rinsing. The rinsing frequency was divided into: never, or 
seldom (every other day), or twice daily. 
 
 Other oral hygiene aids:  
The use of any additional oral hygiene aids was established. These included: 
water pick, interdental brush, or none. 
 
 Oral hygiene instructions received prior to implant therapy. 
Each participant was asked if they received instructions on how to clean 
around the implant before the implant and crown on the implant was placed. 
 
4.5.  Calibration of instrument and researcher  
 
 Vivacare TPS® probe‘s reproducibility of a constant probing force 
 
Initially the ability of the Vivacare TPS® probe tips (Figure 4) to reproduce a constant 
probing force was tested with the use of a mechanical testing machine, the Zwick Material 
Prufeng 1446 Test Xpert Machine® (Figure 5).  
 
Three of the metal Vivacare TPS® probe tips adapted to one handle was selected to test 
whether there were differences in force between the probe tips. Each metal probe tip was 
tested three times (Figure 6). 
 
The probe tip was balanced perpendicularly towards the flat weighing surface of the 
electronic balance arm (Figure 7). The electronic balance arm was under manual control at a 
speed of 5 mm/min and a downwards pressure was applied through the electronic balance 
arm and onto the spring arm of the probe until the line on the probe tip and handle were on 
the same level. 
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Figure 4:  The Vivacare TPS® periodontal probe consists out of a handle and three 
different probe tips: metal, plastic and flexible. The tip has a spring system 
that controls the pressure which is transferred to the probe tip.  
 
 
 
Figure 5:  The Zwick Material Prufeng 1446 Test Xpert Machine’s® electronic balance 
arm which was under manual control at a speed of 5 mm/min.  
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Figure 6:  Three Vivacare TPS® metal probe tips which was each measured separately 
on the same handle. 
 
 
 
Figure 7:  The metal probe tip is adjusted perpendicularly towards the flat weighing 
surface of the electronic balance arm of the machine. 
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Two examiners (examiner 1 and 2) took the measurements independently. Examiner 1 was 
positioned at the level of the probe and flat weighing surface of the electronic balance arm. 
This examiner indicated to examiner 2 when the lines on the handle and probe tip 
coincided. Examiner 2 was positioned in front of the computer and read and recorded the 
force (N), on the verbal command of examiner 1.  
 
Table 1:  The average measurements and force evaluated for Vivacare TPS® probe tip 
number 1. 
 
Probe Tip number 1 
Force (N)  Begin measurement (mm)  End measurement (mm) 
0.33    222.523    220.365 
0.33    222.749    220.462 
0.30    222.383    220.331 
 
Table 2:  The average measurements and force evaluated for Vivacare TPS® probe tip 
number 2. 
 
Probe Tip number 2 
Force (N)  Begin measurement (mm)  End measurement (mm) 
0.25    216.339    214.706 
0.23    216.537    214.704 
0.25    216.360    214.808 
 
Table 3:  The average measurements and force evaluated for Vivacare TPS® probe tip 
number 3. 
  
Table 3: Probe Tip number 3 
Force (N)  Begin measurement (mm)  End measurement (mm) 
0.16    216.005    214.585 
0.15    217.532    215.904 
0.18    217.662    216.152 
 
After the three probe tips was tested, it was decided to used probe tip number 3 as a mean 
force of 0.163 N was obtained. This is less than the 0.2 N, which is the approximate estimate 
given by the manufacturer. 
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Furthermore, in concurrence with the study by Bergenholtz et al (2000), reproducible 
measurements of the Vivacare TPS® probe was high when the same probe tip was used with 
the same handle. Therefore to ensure standardization the same handle and probe tip 
number 3 was used for each peri-implant examination.  
 
Throughout the study, after every ten patients evaluated, the Vivacare TPS® probe tip 
number 3’s ability to reproduce the same force was evaluated with the Zwick Material 
Prufeng 1446 Test Xpert Machine® using the above mentioned method and a mean force of 
less than the required 0.2N was obtained throughout. 
 
 Inter-examiner calibration 
 
The primary researcher’s ability to reproduce a consistent positive result for bleeding which 
was in agreement with  a second more experienced clinical supervisor (i.e. golden standard) 
was evaluated by determining the kappa values. The latter can be defined as the actual 
measure of agreement with the degree of agreement which would have occurred by 
chance: 
 
 
Kappa = (Observed Agreement – Expected Agreement) / 1 – Expected Agreement 
 
 
To this end patients without implants were examined at six peri-sulcular sites around either 
the upper or lower first molars. Bleeding on probing was measured. The six peri-sulcular 
sites around the first molar evaluated included the mesio-buccal, mid-buccal, disto-buccal, 
disto-palatal/lingual, mid-palatal/lingual, and mesio-palatal/lingual.  
 
The primary researcher evaluated the patient first and allowed a period of 15 minutes to 
elapse before the more experienced clinical supervisor (i.e. golden standard) evaluated the 
same patient’s tooth. In-between each exam the patient rinsed with 0.2% digluconate 
chlorhexidine mouth rinse (alcohol based) to remove any residual blood from the peri-
sulcular area.  
 
After the examination by the experienced clinical supervisor a period of 15 minutes elapsed 
before the primary researcher evaluated the same patient’s tooth for the second time. In-
between each exam the patient rinsed with 0.2% digluconate chlorhexidine mouth rinse 
(alcohol based) to remove any residual blood from the peri-sulcular area. 
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The kappa statistic was then evaluated for the readings at the six sites between the two 
examiners.  
 
Complete agreement between the examiners resulted in a kappa value = 1. Total 
disagreement the kappa statistic = 0. If the kappa value is more than 0.8 then there is good 
agreement between examiners. A kappa statistic between 0.6 and 0.8 indicated substantial 
agreement; however a value between 0.4 and 0.6 indicates moderate agreement. 
 
Table 4: The kappa values for the first inter-examiner calibration between the 
primary researcher and the golden standard. 
 
Peri-sulcular sites Kappa-values Quality of agreement
Mesio-buccal 0.634 Substantial agreement
Mid-buccal 1 Total agreement
Disto-buccal 0.7 Substantial agreement
Mesio-palatal/lingual 0.815 Good agreement           
Mid-palatal/lingual 0.667 Substantial agreement
Disto-palatal/lingual 0.526 Moderate agreement  
 
Table 5: The kappa values for the second inter-examiner calibration between the 
golden standard and the primary researcher. 
 
Peri-sulcular sites Kappa-values Quality of agreement
Mesio-buccal 1 Total agreement                          
Mid-buccal 1 Total agreement  
Disto-buccal 0.667 Substantial agreement
Mesio-palatal/lingual 1 Total agreement                        
Mid-palatal/lingual 1 Total agreement                          
Disto-palatal/lingual 1 Total agreement                           
 
The majority of the above listed kappa values (Tables 1 and 2) interpreting the quality of 
agreement was found to be more than substantial agreement, which is considered to be 
satisfactory to establish inter-examiner calibration. 
 
 Intra-examiner calibration 
 
The primary researcher’s skill to reproduce a consistent positive result for bleeding was 
measured. The primary researcher evaluated the patient first and a period of 30 minutes 
elapsed before evaluating the same patient’s tooth for a second time. After each 
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measurement the patient rinsed with 0.2% digluconate chlorhexidine mouth rinse (alcohol 
based) to remove residual blood from around the tooth. 
 
The kappa statistic was then evaluated for the readings at the six sites between the two 
examinations conducted by the primary researcher. 
 
Table 6: The kappa values for the intra-examiner calibration of the primary 
researcher. 
 
Peri-sulcular sites Kappa-values Quality of agreement
Mesio-buccal 0.634 Substantial agreement                          
Mid-buccal 1 Total agreement                      
Disto-buccal 0.7 Substantial agreement
Mesio-palatal/lingual 0.815 Good agreement                        
Mid-palatal/lingual 0.667 Substantial agreement                          
Disto-palatal/lingual 0.526 Moderate agreement                           
 
The majority of the kappa values listed in Table 3 above is more than substantial agreement 
which is considered satisfactory to establish intra-examiner calibration. 
 
4.6.  Disinfection and sterilization of instruments 
 
Disinfection completely destroys micro-organisms on non-living objects which may cause 
disease, except for the bacteria spores. Sterilization completely eradicates micro-organisms 
on non-living objects by means of a physical or chemical procedure (Rutala and Weber, 
2004: 702). 
 
High level disinfectants are used to eradicate all micro-organisms on instruments after an 
exposure time of less than 45 minutes.  
 
Centre for Disease Control and Prevention (CDC)  recommends high level disinfectants may 
inactivate the human immunodeficiency virus (HIV), hepatitis B virus (HBV) as well as 
secretions contaminated with pulmonary tuberculosis (Rutala and Weber, 2004: 702, 704).  
 
Since only one Vivacare TPS probe handle and specific probe tip number 3 was used 
throughout the study, there was insufficient time available between patients to gas sterilize 
the instrument. To this end a high level disinfectant (MedDis®) was used in between 
patients and at the end of the day the Vivacare TP®S probe was taken for gas sterilization 
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with ethylene oxide. After each patient the probe was mechanically cleaned with a brush 
and running water, and then immersed in a tray containing MedDis® for a period of 30 
minutes after which the instrument was rinsed under running water.  
 
MedDis® (Figure 8) is explicitly indicated for the chemical reprocessing of thermo-sensitive 
surgical instruments. The chemical disinfects within 10 minutes and sterilizes after 30 
minutes of soaking. It is bactericidal, fungicidal, virucidal, mycobactericidal and sporicidal. 
 
 
A             B   
 
Figure 8:  MedDis® container (A); (B) illustrates the reverse of the container with the 
manufacturer instructions. 
 
At the end of each day, the Vivacare TPS® probe underwent ethylene oxide (ETO) 
sterilization (Figure 9 and 10). The full sequence of ETO sterilization begins with pre-
conditioning and humidification, gas introduction, exposure, evacuation, and air washes. 
The full duration of the complete cycle may take between 2 to 5 hours after which an 
additional ventilation time of 8 to 12 hours is required. Major drawbacks of this process are 
the extended cycle duration, and the harmful effect on staff exposed to the gas (Rutala and 
Weber, 2004: 268). 
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Figure 9:  Ethylene oxide (ETO) is used to sterilize medical instruments that cannot be 
steam sterilized. The picture above illustrates the machine into which the 
instruments are placed overnight for a complete cycle. Note the ventilation 
channel at the back of the machine to evacuate the harmful gas.  
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Figure 10: Ethylene oxide (ETO) gas cartridge. ETO gas is colourless, flammable, and 
poisonous to staff. 
 
4.7.   Data processing and analysis 
 
The source of the data was the information gathered on the standardized data information 
form collected during the clinical examination. The data was captured by the principal 
investigator on the standardized data information form and analysed using the Epi Info® and 
Microsoft Excel® statistical program. The data was backed up on two different devices. One 
device was kept in the office and the other device was taken home every night to ensure 
that it was not at the same site as the computer used for the data capturing. 
 
•  Data analysis 
 
The information assimilated was used to determine a prevalence of peri-implant mucositis 
in the sample population and its association with various risk variables.  
 
The null hypothesis was tested with a statistical test, the chi-squared test for not normally 
distributed data. This was used to determine if there was a statistically significant 
relationship between the presence of peri-implant mucositis and the various systemic and 
local risk factors as well as the gender of the patients. 
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4.8.  Ethics 
 
•  Ethics concerning research approval 
 
The research proposal was approved by the Senate Ethics Research Committee of the 
University of the Western Cape (Appendix 5).  
 
• Patient autonomy 
 
Participation of patients in the study was voluntary. The patient had the right to withdraw 
from the study at any stage, without prejudice. Patients were required to understand the 
information that was provided by the researcher and social differences or learning 
disabilities were addressed when obtaining informed consent (Appendix 2 and 4). Patients 
received a scale and polish even if he or she did not want to participate in the study. 
 
• Management of potential implant complications 
 
When any implant complications or disease was identified in the study population, the 
researcher informed the patient of such complications and appropriately referred after 
explanation and education of possible causes therefore.  
 
• Treatment options and time aspects regarding management 
 
The researcher was not obliged to provide treatment for the patient, but appropriate 
referral was arranged therefore 
  
• Patient confidentiality 
 
Patient information was kept confidential. Information was collected on a data collection 
form (Appendix 1) that excluded the patient’s name. The data collection form only had the 
patients study number and file number with a list of corresponding names only on file in the 
researcher’s office.  The personal information of the patients was destroyed once the data 
analysis was completed and the results of the study was discussed and written up. 
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CHAPTER 5: 
RESULTS 
 
 
5.1. Introduction 
A study sample of 74 implant patients was investigated to determine the relationship 
between the presence of peri-implant mucositis and the various systemic and local risk 
factors.  Different variables were compared and the appropriate statistical tests employed 
to analyse data. 
 
 A 95% confidence interval was accepted throughout the statistical analysis and a p-value of 
less than 0.05 was accepted as statistically significant. 
 
Table 7: Odds ratios; 95% confidence intervals (C/I); and statistical significance; for 
developing bleeding on probing when responding to various local and 
systemic risk factors. 
 
Risk fackors  
Odds 
Ratio   C/I Lower Limit C/I Upper Limit Chi square P-value 
Gender  1.081 0.355 3.292 0.019 0.891 
Smoking 0.449 0.142 1.416 1.921 0.166 
Diabetes 1.286 0.126 13.086 0.045 0.831 
Dental Arch Position * 7.333 1.550 34.696 7.784 0.005 
Diameter Implant 1.895 0.387 9.277 0.638 0.425 
Follow-up time after placement 1.350 0.383 4.764 0.219 0.640 
Implant retained crown 1.708 0.603 4.833 1.027 0.311 
Keratinized Gingival Width * 0.322 0.110 0.940 4.492 0.034 
Oral Hygiene Status * 3.808 1.223 11.855 5.692 0.017 
Brushing Frequency 1.508 0.372 6.111 0.334 0.563 
Flossing Frequency 1.108 0.401 3.063 0.039 0.844 
Mouthwash Frequency 0.589 0.147 2.357 0.570 0.450 
Other Oral Hygiene Aids 0.983 0.320 3.013 0.001 0.975 
Water pick 1.064 0.19 5.949 0.005 0.944 
Interdental Brush 0.942 0.257 3.456 0.008 0.928 
Prior Oral Hygiene Instructions * 4.267 1.432 12.716 7.266 0.007 
 
(*  regarded as statistically significant.) 
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5.2.  General prevalence of peri-implant mucositis 
 
The prevalence rate of peri-implant mucositis was of 70.3%. 
 
5.3. Demographics of the study population 
 
Of the seventy four (74) patients evaluated, fifty three (53) patients were female of which 
69.8% was positive for peri-implant mucositis. Twenty one (21) males were included into the 
study of which 71.4% were positive for peri-implant mucositis.  
 
There was no statistically significant prevalence difference between the two groups (gender 
and bleeding on probing). 
 
The age distribution of the study sample was comprehensive and ranged from 20 to 84 
years. The patient’s age was allocated into various age groups and the succeeding pie chart 
(Figure 11) illustrates the age distribution of the study sample. Those younger than 49 years 
represented 19 participants (36.54%) of the sample and those 50 years and older 
represented 33 participants (63.46%) of the sample. 
 
 
KEY FOR AGE:
1 = 20 to 29 years
2 = 30 to 39 years
3 = 40 to 49 years
4 = 50 to 59 years
5 = 60 to 69 years
6 = 70 to 79 years
7 = 80 to 89 years  
 
Figure 11:   Age distribution of study sample positive for peri-implant mucositis. 
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5.4.  Systemic factors’ association with peri-implant mucositis 
 
Diabetes and smoking were two systemic risk factors which were investigated. There were 
no statistically significant differences between these two groups and peri-implant mucositis. 
Sample sizes of diabetics and smokers’ positive for peri-implant mucositis was too small for 
any inferences to be made.  
 
 Smoking 
 
A patient was considered a smoker when they reported smoking tobacco at the time of the 
implant check-up.  
 
Table 8:  A frequency table for smoking and peri-implant mucositis. 
 
  
 
 
 
 
 
 
 
 
 
 Chi-square = 1.921 
 P-value = 0.166 
 
The Chi-square statistic of 1.921 represented a probability of 0.166 which was more than 
0.05; therefore there was no significant difference between the groups.   
 
 Diabetes 
 
The presence of diabetes was based on the patient’s report and no differentiation was 
made between type 1 and 2 diabetes. No further diagnostic chemical blood tests were 
done. 
 
 
 
 
Bleeding 
 
SMOKING Positive Negative Total 
Yes 9 7 16 
No 43 15 58 
TOTAL 52 22 74 
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Table 9:   A frequency table for diabetes and peri-implant mucositis. 
 
  
 
 
 
 
 
 
 
 
 
 Chi-square = 0.045 
 P-value = 0.831 
 
The Chi-square statistic of 0.05 represented a probability of 0.83 which was more than 0.05; 
therefore there was no significant difference between the groups. 
 
5.5.  Local risk factors related to the implant and their association with peri-
implant mucositis 
 
 Dental arch position 
 
Implants placed in the incisor to canine region of the dental arch where categorised as being 
anterior implants. Posterior implants were implants placed in the premolar to molar regions 
of the dental arch.  
 
Table 10:  A frequency table for dental arch position of the implant and bleeding on 
probing. 
 
 
 
 
 
 
 
 
 
 
Bleeding 
 
DIABETIC Positive Negative Total 
Yes 3 1 4 
No 49 21 70 
TOTAL 52 22 74 
 
Bleeding 
 
ARCH POSITION  Positive Negative Total 
Anterior 22 2 24 
Posterior 30 20 50 
TOTAL 52 22 74 
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 Chi-square = 7.784 
 P-value = 0.005 
 
The Chi-square statistics of 7.784 represented a probability of 0.005 which was less than 
0.05; therefore there was a significant difference between the groups.   
 
 Diameter implant 
 
The implant diameter was categorised into standard (between 3.7mm and 4.2 mm) or wide 
(5 mm and 6 mm).  
 
Table 11:  A frequency table for implant diameter and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 
 
 
 Chi-square = 0.638 
 P-value = 0.425 
 
The Chi-square statistic of 0.638 represented a probability of 0.425 which was more than 
0.05; therefore there was no significant difference between the groups. 
 
 Implant retained crown  
 
The type of implant restored crown used on each implant was categorised as either being a 
screw-retained or cement-retained crown. 
 
 
 
 
 
 
Bleeding 
 
IMPLANT DIAMETER Positive Negative Total 
Standard 48 19 67 
Wide 4 3 7 
TOTAL 52 22 74 
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Table 12:   A frequency table for implant retained crown and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 
 
 Chi-square = 1.027 
 P-value = 0.311 
 
The Chi-square statistic of 1.027 represented a probability of 0.311 which was more than 
0.05; therefore there was no significant difference between the groups.   
 
 Follow-up time from implant placement 
 
The time that elapsed from implant placement till implant follow-up for each participant, 
was calculated afterwards from the date of implant placement recorded in the implant 
record book kept in the OMEP Department and the date of the implant follow-up 
appointment. The mean follow-up time for each of the 52 participants evaluated with 
bleeding after probing was 3 years and 4 months. 
 
The follow-up time was divided into two groups: 1 to 2 years; and more than 2 years.  
 
Table 13: A frequency table for follow-up time from implant placement and bleeding 
after probing. 
 
 
 
 
Bleeding 
 
CROWN RETENTION Positive Negative Total 
Cement 37 13 50 
Screw 15 9 24 
TOTAL 52 22 74 
 
Bleeding 
 
FOLLOW UP TIME Positive Negative Total 
1 to 2 years 12 4 16 
More than 2 years 40 18 58 
TOTAL 52 22 74 
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 Chi-square =  0.219 
 P-value = 0.640 
 
The Chi-square statistic of 0.219 represented a probability of 0.640 which was more than 
0.05; therefore there was no significance between the groups. 
 
5.6.  Local risk factors related to the keratinized gingival width around the 
implant and its association with peri-implant mucositis 
 
Keratinized gingival width was divided three categories: less than 1mm; equal to and more 
than 1mm but less than 2mm; equal to and more than 2mm. However, due to a small 
sample (five cases) of keratinized gingival width less than 1 mm, the three categories were 
collapsed into two categories: less than 2 mm; 2mm and more. 
 
Table 14:  A frequency table for keratinized gingival width and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 
 Chi-square = 4.492 
 P-value = 0.034 
 
The Chi-square statistic of 4.492 represents a probability of 0.034 which was less than 0.05; 
therefore there was no significant difference between the groups.  
 
5.7.  Local risk factor related to oral hygiene and its association with peri-
implant mucositis 
 
 Oral Hygiene Status 
 
The oral hygiene status of the patient was divided into three categories: poor, fair or good. 
For statistical evaluation the categories for oral hygiene status of the patient was collapsed 
into two categories: poor to fair oral hygiene; and good oral hygiene.  
 
Bleeding 
 
KERATINIZED GINGIVAL 
WIDTH 
Positive Negative Total 
Less than 2mm 11 10 21 
2mm and more 41 12 53 
TOTAL 52 22 74 
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Table 15:  A frequency table for oral hygiene status and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 
 Chi-square = 5.692 
 P-value = 0.017 
 
The Chi-square statistic of 5.692 represented a probability of 0.017 which was less than 
0.05; therefore there was a significant difference between the groups.  
 
 Brushing frequency 
 
The brushing frequency was divided into two categories: never or every other day; or twice 
daily. 
 
Table 16:  A frequency table for brushing and bleeding after probing. 
 
 
 
 
 Chi-square = 0.334 
 P-value = 0.563 
 
The Chi-square statistic of 0.334 represented a probability of 0.563 which was more than 
0.05; therefore there was no significant difference between the groups.  
 
Bleeding 
 
ORAL HYGIENE STATUS Positive Negative Total 
Poor to fair 44 13 57 
Good 8 9 17 
TOTAL 52 22 74 
 
Bleeding 
 
BRUSHING FREQUENCY Positive Negative Total 
Once 10 3 13 
Twice 42 19 61 
TOTAL 52 22 74 
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 Flossing frequency 
 
The flossing frequency was divided into two categories: never or every other day; and every 
day.  
 
Table 17:  Frequency table for flossing and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 
 Chi-square =  0.039 
 P-value = 0.844 
 
The Chi-square statistic of 0.039 represented a probability of 0.844 which was more than 
0.05; therefore there was no significant difference between the groups.  
 
 Rinsing with mouthwash 
 
It was not established what type of mouthwash each patient was using, only the frequency 
of rinsing. The rinsing frequency was divided into: never or seldom; and twice daily. 
 
Table 18:  Frequency table for rinsing and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 
 
 Chi-square = 0.570 
 
Bleeding 
 
FLOSSING FREQUENCY  Positive Negative Total 
Never to seldom 32 13 45 
Every day 20 9 29 
TOTAL 52 22 74 
 
Bleeding 
 
RINSING FREQUENCY  Positive Negative Total 
Never - every other day  41 19 60 
Everyday 11 3 14 
TOTAL 52 22 74 
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 P-value = 0.450 
 
The Chi-square statistic of 0.57 represents a probability of 0.45 which is more than 0.05; 
therefore no significant difference between the groups. 
 
 Other oral hygiene aids 
 
From each participant it was assimilated if any additional oral hygiene aids other than 
brushing, flossing and using a mouthwash was used. Patients were given three options: 
water pick, interdental brush, or none.  
 
For statistical evaluation three separate frequency tables was made: other oral hygiene aids; 
water pick; and interdental brush. 
 
Table 19:  The frequency table of other oral hygiene aids and bleeding on probing. 
 
 
 
 Chi-square = 0.001 
 P-value = 0.975 
 
The Chi-square statistic of 0.001 represented a probability of 0.975 which was more than 
0.05; therefore there was no significant difference between the groups.  
 
Table 20: A frequency table for the use of a water pick and bleeding after probing. 
 
 
 
 
 
 
 
 
Bleeding 
 
OTHER ORAL HYGIENE AIDS Positive Negative Total 
Yes 14 6 20 
No 38 16 54 
TOTAL 52 22 74 
 
Bleeding 
 
WATERPICK Positive Negative Total 
Yes 5 2 7 
No 47 20 67 
TOTAL 52 22 74 
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 Chi-square = 0.005 
 P-value = 0.944 
 
The Chi-square statistic of 0.005 represents a probability of 0.944 which was more than 
0.05; therefore there was no significance between the groups.  
 
Table 21: A frequency table for the use of an interdental brush and bleeding after 
probing. 
 
 
 
  
 
 
 
 
 
 
 Chi-square = 0.008 
 P-value = 0.928 
 
The Chi-square statistic of 0.008 represented a probability of 0.928 which was is more than 
0.05; therefore there is no significance between the groups. 
 
 Oral hygiene instructions prior to commencing implant treatment 
 
Each participant was asked if they received instructions how to clean around the implant 
before the implant and crown on the implant was placed. 
 
Table 22:  Frequency table representing pre oral hygiene instructions and bleeding on 
probing. 
 
 
 
 
 
 
 
 
Bleeding 
 
INTERDENTAL BRUSH Positive Negative Total 
Yes 9 4 13 
No 43 18 61 
TOTAL 52 22 74 
 
Bleeding 
 
PRE ORAL HYGIENE  
INSTRUCTIONS 
Positive Negative Total 
Yes 32 6 38 
No 20 16 36 
TOTAL 52 22 74 
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 Chi-square = 7.266 
 P-value = 0.007 
 
The Chi-square statistic of 7.27 represents a probability of 0.007 which is more than 0.05; 
therefore there is a significant difference between the groups.  
 
 
 
Figure 12:  Pre oral hygiene instructions and bleeding on probing. 
 
5.8. Inter-relationship between peri-implant mucositis and selected risk     
factors 
 
 Anterior implants associated with implant crown retention and 
bleeding after probing 
 
Table 23: Frequency table for anterior implants associated with implant crown 
retention and peri-implant mucositis. 
 
 
 
 
 
 
  Bleeding   
CROWN RETENTION Positive Negative Total 
Cement 17 1 18 
Screw 5 1 6 
TOTAL 22 2 24 
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 Chi-square = 0.727    
 P-value = 0.394 
 Odds ratio = 3.400 
 
The majority of anterior cement-retained crowns (77.27%) were positive for bleeding after 
probing. The majority of cement-retained crowns (94.44%) in the anterior dental arch were 
positive for bleeding after probing. 
 
The Chi-square statistic of 0.727 represented a probability of 0.394 which is more than 0.05; 
therefore there was no significant difference between the groups. 
 
 Posterior implants associated with implant retained crown and peri-
implant mucositis 
 
Table 24:  Frequency table for posterior implants associated with implant retained 
crown and peri-implant mucositis. 
 
 
 
 
 
 
 
 
 Chi-square = 0.232 
 P-value = 0.630 
 Odds ratio = 1.333 
 
The majority of posterior implants had cement-retained crowns (62.50%) positive for 
bleeding. However the majority of crowns on posterior implants positive for bleeding were 
66.67%. 
 
The Chi-square statistic of 0.232 represented a probability of 0.630 which was more than 
0.05; therefore there was no significant difference between groups.  
 
 
 
  Bleeding   
CROWN RETENTION Positive Negative Total 
Cement 20 12 32 
Screw 10 8 18 
TOTAL 30 20 50 
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 Peri-implant mucositis associated with keratinized gingival width and 
dental arch position 
 
The majority of patients (95.83%) with bleeding after probing and anterior placed implants 
had a keratinized gingival width of 2 mm and more. 
 
Table 25: Frequency table of peri-implant mucositis associated with keratinized 
gingival width and dental arch position. 
  
 
 
 
 
 
 
 
 
 Chi-square = 10.245 
 P-value = 0.001 
 Odds ratio = 0.065 
 
The odds for having keratinized gingival width of less than 2mm around anterior implants 
are 0.07 times the odds of posterior implants.  
 
Therefore the odds for having keratinized gingival width of less than 2mm around an 
anterior implant are 93% less than the odds for those around posterior implants. 
 
The Chi-square statistic of 10.24 represented a probability of 0.001 which is less than 0.05; 
therefore there was a significant difference between the groups.  
 
 Peri-implant mucositis associated with flossing and receiving prior oral 
hygiene instructions 
 
The majority of participants (53.33%) who did receive oral hygiene instructions prior to 
implant   placement never or seldom flossed. 
 
  Keratinized Gingival Width   
ARCH 
POSITION 
Less than 2mm 2mm and more Total 
Anterior 1 23 24 
Posterior 20 30 50 
TOTAL 21 53 74 
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Table 26:  Frequency table of peri-implant mucositis associated with flossing 
frequency and receiving prior oral hygiene instructions. 
 
 
 
 Chi-square = 0.181 
 P-value = 0.671 
 Odds ratio = 0.817 
 
The Chi-square statistic of 0.181 represented a probability of 0.671 which was more than 
0.05; therefore there was no significant difference between the groups.   
 
 Peri-implant mucositis associated with oral hygiene status and flossing 
frequency 
 
Table 27:  Frequency table of peri-implant mucositis associated with oral hygiene 
status and flossing frequency. 
 
 
 
 
 
 
 
 
 
 Chi-square = 3.570 
 P-value = 0.058 
 Odds ratio = 2.857 
 
The majority of participants (66.67%) with poor to fair oral hygiene status flossed never or 
seldom. 
  Prior Oral Hygiene Instructions   
FLOSSING No Yes Total 
Never to seldom 21 24 45 
Every day 15 14 29 
TOTAL 36 38 74 
  Flossing Frequency   
Oral Hygiene Status Never to seldom Every day Total 
Poor to fair 38 19 57 
Good 7 10 17 
TOTAL 45 29 74 
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The Chi-square statistic of 3.570 represents a probability of 0.058 which was more than 
0.05; therefore there was no significant difference between the groups. 
 
5.9. Description of statistically significant findings: 
 
 
 
Figure 13:  Statistically significant factors associated with bleeding on probing. 
 
 Dental arch position 
 
Participants with anterior implants that presented with bleeding after probing were 20 
(91.67%) while only 30 (60%) participants with posterior implants presented with bleeding 
after probing.   
 
The odds for having an anterior placed implant of bleeders were 7.33 times the odds of non-       
bleeders.  
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 Keratinized gingival width 
 
Participants with a keratinized gingival width of 2mm and more who was positive for 
bleeding after probing was 41 (77.36%) and only 11 (52.38%) participants with a keratinized 
gingival width of less than 2mm had bleeding after probing. 
 
The odds of participants having a keratinized gingival width of less than 2 mm of non-
bleeders were 68% less the odds of bleeders. 
 
Participants that did not present with bleeding after probing are 0.68 times more likely to 
have a keratinized gingival width of less than 2mm compared to those who did bleed. 
 
 Oral hygiene status 
 
The majority of participants (77.03%) had poor to fair oral hygiene while less than a third of 
the sample (22.97%) had good oral health. Participants with poor to fair oral hygiene 44 
(77.19%) were positive for bleeding after probing, while only 8 (47.06%) participants with 
good oral hygiene were positive for bleeding after probing. 
 
The odds for having a poor to fair oral hygiene status of bleeders were 3.808 the odds of 
non-bleeders. 
 
Participants that did not present with bleeding after probing are 1.64 times more likely to 
have poor to fair oral hygiene status compared to those who did not bleed. 
 
 Prior oral hygiene instructions 
 
The majority of participants (61.54%) who presented with bleeding after probing did receive 
oral hygiene instructions before implant therapy. 
 
The odds for not having pre oral hygiene instructions of bleeders are 4.267 times the odds 
of non-bleeders.  
 
Participants that did not present with bleeding on probing are 1.52 times more likely to 
have not received oral hygiene instructions prior to implant placement compared to those 
who did present with bleeding.  
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5.10. Null hypothesis 
 
The null hypothesis was therefore rejected when considering the four selected risk factors: 
 
 Anterior dental arch position  
 
 Wider keratinized gingival widths  
 
 Poor to fair oral hygiene status  
 
 Prior oral hygiene instructions   
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CHAPTER 6: 
DISCUSSION 
 
 
This cross-sectional study aimed to determine the prevalence of peri-implant mucositis and 
its associated risk factors in patients treated with single implants, which were restored for a 
minimum of one year in the Department of OMEDP at UWC.  
 
The findings of this study reveal the prevalence rate of peri-implant mucositis to be 70.3% 
per implant site. It is considerably higher in comparison to international studies whose 
prevalence rates of peri-implant mucositis range between 30.7 - 50% of implant sites and 
63.4 - 80% of patients (Lindhe and Meyle, 2008: 284; Heasman et al, 2010: 512). 
 
No significant gender predilection with regard to the prevalence of peri-implant mucositis 
was found, which is in concordance with the findings of other such studies.  
 
To date there is no available South African literature reporting on the prevalence of peri-
implant disease. A plausible reason for the high prevalence rate found in this study 
population could be the absence of a defined maintenance program for patients receiving 
implant restorations. In the present study the follow-up period for participants ranged from 
one year to seven years (mean of 3 years and 4 months). The majority of participants 
(76.92%) with bleeding on probing only presented for a follow-up examination, 2 years 
following placement of the implant prosthesis. Most participants did not comply with the 
recommended maintenance care and others only presented when prosthodontics 
maintenance or repair was required. It can therefore not be uniformly stated that the 
follow-up appointment given to participants as part of the study was the first maintenance 
care appointment for all the participants. In the literature the frequency of maintenance 
visits to prevent disease progression is still unclear. In addition, the fact that there are fewer 
studies on peri-implant mucositis than peri-implantitis means that there is a lack of follow-
up of the disease progression in general. Another possible reason for the high prevalence 
rate in this study population may be as a result of a small sample size. The study included 74 
implant patients from the initial list of 100 suitable candidates. Not all randomly selected 
suitable candidates were included for analysis in the study. This is because:  
 
•  Eight patients did not want to come in for a follow-up evaluation. 
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• Three patients moved to different provinces and could not come in for a follow-up 
evaluation. 
 
• Six patients were not contactable for various reasons. 
 
• Nine patients did not receive the prosthetic components and crown after their 
implant surgery was completed due to financial constraints.  
 
Of all the risk factors evaluated in this study, only four were found to be statistically 
significant and included: if the position of the implant crown was in the anterior dental arch 
position; wider keratinized gingival widths; poor to fair oral hygiene status; and prior oral 
hygiene instructions.  
 
The role of local risk factors, i.e. “position of dental implant in the arch” and “width of 
keratinized gingival tissue”, in the development of peri-implant mucositis was an 
unexpected finding, because studies in the literature reveal different results. 
 
In contrast, this study has revealed that at long term follow-up there is a statistically greater 
prevalence of peri-implant mucositis (diagnosed by bleeding after probing) around implants 
in the anterior area of the mouth. The anterior area also has a greater prevalence of wider 
dimensions of keratinized gingiva. A study by Greenstein et al (2010: 115) maintained the 
contrary and found that wider keratinized gingival widths around the implant site may prove 
valuable to the peri-implant soft tissue health. Furthermore, in the literature there is no 
evidence with regards to what effect the position of the dental implant in the dental arch 
will have on the development of peri-implant disease. 
 
Additionally, analysis of the data has revealed that the majority (77.27%) of implant-
supported cement retained restorations in the anterior area have presented with bleeding 
on probing. This is also in direct contrast with the literature. A systematic review and meta-
analysis (De Brandão et al, 2013: 287 – 295) has shown that there is no evidence to support 
differences in the marginal bone loss through indirect comparison between cement and 
screw-retained restorations. A randomized controlled trial with 10 year follow-up has shown 
that, within the limitations of the study, there was no evidence of a significant difference in 
the clinical behaviour of the peri-implant marginal soft tissues when cemented or screw-
retained single-tooth implant restorations were provided (Vigolo et al, 2012: 355 -364). 
Other long term follow-up studies have shown better peri-implant soft tissue reactions 
around cement-retained implant supported restorations compared to screw-retained 
restorations (Nissan et al, 2011: 11-2 – 1107).  
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An explanation for the greater prevalence of peri-implant mucositis in the anterior area 
might be the extrusion of cement around the margins of a cement-retained restoration 
which, given time in a vascular environment of peri-implant gingiva could elicit a foreign 
body inflammatory reaction which is clinically diagnosed as peri-implant mucositis. This 
would explain the lack of effect of good plaque control instruction on peri-implant mucositis 
as the mucositis is a foreign body reaction and not a plaque-induced lesion. Animal studies 
on root canal fillers (Silva-Herzog et al, 2011: 440 -446) have shown reactions in connective 
tissue to these materials and it is feasible that peri-implant tissues will also react to 
extruded cement materials resulting in inflammation in these tissues. Further research to 
investigate this theory is difficult to do as the ideal diagnostic method to determine whether 
there has been extrusion of cement around a crown margin is direct visual inspection which 
would mean crown removal. Another possible reason explaining the majority of cement-
retained crowns presenting with peri-implant mucositis, is that the participants in this study 
had their cement-retained crowns placed by different prosthodontic dental registrars. Their 
lack of experience may have contributed to possible excessive amounts of cement being 
used, eliciting a foreign body reaction in the peri-sulcular tissues. 
 
Poor oral hygiene and bacterial plaque is considered to be the major risk variable for peri-
implant disease. Peri-implant soft tissues react to the bacterial plaque and result in local 
inflammation. Studies have proven that patients with poor oral hygiene and high numbers 
of bacterial plaque are strongly associated with peri-implant disease (Grusovin et al, 2010: 
3). Results in this study are in agreement with the literature and shows a statistically 
significant association between poor to fair oral hygiene and peri-implant mucositis. Less 
bleeding occurred in participants with good oral hygiene.  In addition, the majority of the 
sample (63.46%) was 50 years and older and may give a possible explanation for poor to fair 
oral hygiene being so high. A possible lack in dexterity in this age group may have resulted in 
a lack of proper home cleaning around the implants. This may be the possible cause for the 
bulk of patients not flossing around the implants and the increase in peri-implant mucositis 
around implants.  Furthermore the brushing frequency, flossing habit, rinsing frequency, or 
other oral hygiene aids used did not have a statistically significant effect on the overall oral 
hygiene of the participants. Interestingly the majority of participants (54%) did not use any 
other oral hygiene aids than brushing and flossing. However, it can be postulated that even 
if these participants were flossing around the anterior cement-retained implant crowns, it 
still would not have made a difference as the excessive cement would not have been 
removed or dislodged. 
 
With regards to the participants who received oral hygiene instructions prior to the 
initiation of implant therapy, the results in this study found a statistically significant 
association (p= 0.007) between the groups.  The majority of participants (61.54%) who 
presented with bleeding after probing did receive oral hygiene instructions before implant 
therapy. The odds for not having pre oral hygiene instructions of non-bleeders were 4.267 
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times the odds of bleeders. This result was unexpected and may be possibly related to the 
loss of dexterity in the majority of the sample being over 50 years of age. The latter could be 
explained by the majority of participants (53.33%) who did receive oral hygiene instructions 
prior to implant placement who never or seldom flossed. In addition the bulk of participants 
(66.67%) with poor to fair oral hygiene status also flossed never or seldom. However one 
must bear in mind that a participant will not be able to remove the excess cement in the 
peri-sulcular area eliciting a foreign body reaction with flossing.  
 
Therefore oral hygiene instructions alone prior to the initiation of implant therapy are no 
assurance for a reduced risk of later developing peri-implant disease. There are many other 
co-founding factors which may also influence the outcome of peri-implant soft tissue health. 
In the literature there are limited amount of studies that looked at combined risk factors 
and their synergistic effect on implant survival. These factors may not seem significant when 
analysed individually, but may become so when they occur together. In this study we found 
that anterior placed implants with cement restored crowns were at greater risk for 
developing peri-implant disease. The majority of anterior implants that presented with 
bleeding after probing (77.27%) had cement-retained crowns. Furthermore anterior 
implants with a keratinized gingival width of 2 mm and more were also more likely to 
present with peri-implant disease and showed a significant difference (p = 0.001).  
 
Weaknesses and strengths of study: 
 
 Sampling error: A sample error of 10% was used in this study. With a maximum 
prevalence rate of peri-implant mucositis of 50% or more expected (as gleaned from 
the literature) and a 10% margin of sampling error the study utilized the minimal 
sample required of 97. In the end only 74 participants contacted out of the 97 
sampled, agreed to come in for examination. As the population size was 120 there 
was not the option of using a sampling error of 5% or less.    
 
 During the completion of the calibration of the primary researcher, each participant 
was asked to rinse with 0.2% Digluconate Chlorhexidine mouth rinse between each 
examination. The latter was done to remove any residual blood form the peri-
sulcular area before the next examiner evaluated the peri-sulcular tissues. In 
retrospect, this was not required and perhaps over cautious and there is no 
literature that deems this necessary.  
 
 Three of the significant risk factors found in this study (i.e. dental arch position, oral 
hygiene status, and prior oral hygiene instructions) each had odds ratio’s which was 
more than 3 indicating a strong association with bleeding after probing. However the 
range between the lower and upper limits of their confidence intervals was very 
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wide, indicating a possible weakness in the results. Their small sample may have had 
an effect on the precision of the results. 
 
 Furthermore the effect that the different implant systems’ surface topography and 
bacterial plaque might have on the peri-implant tissue was not investigated as the 
study only examined the soft tissue around the implant and not the bone.  
 
Hence while no inferences can be made for the majority of risk factors evaluated, the study 
highlights the need for initiating a periodontal supportive maintenance care program for 
patients to ensure optimal long term mucosal health.  It can be proposed that a more rigid 
maintenance programme should be assigned to patients based on the position of the 
implant in the dental arch (anterior), the type of implant supported restoration used 
(cement), and the age and manual dexterity of the patient (above the age of 50 years).  
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CHAPTER 7: 
CONCLUSION AND RECOMMENDATIONS 
 
 
Within the limitations of this cross-sectional study there is a high occurrence of peri-implant 
mucositis with a 70.3% prevalence rate per implant site. 
 
Four risk factors had a statistically significant relationship on peri-implant mucositis. They 
included “anterior dental arch position”; “wider keratinized gingival width”; “poor to fair 
oral hygiene”; and “prior oral hygiene instructions”.  
 
Recommendations 
 
The high prevalence rate obtained from the study population illustrates the importance of a 
regular maintenance programme for patients with implant restored restorations. A more 
rigid maintenance programme are proposed for implant patients with an anteriorly placed 
implant, cement-retained implant supported restoration, and those above the age of 50 
years with loss of dexterity. 
 
Finally, to safeguard optimal long term mucosal health around dental implants it can be 
recommended to use screw-retained implant supported restorations rather than cement-
retained. 
 
Further research is recommended on the various risk factors associated with the onset of 
peri-implant disease. The current study had a limited sample size which was sufficient for 
determining the main aim of the study. A larger sample size is recommended for evaluating 
the various risk factors associated with peri-implant disease to ensure accuracy and 
completeness of results.  
 
As suggested in the literature by Nogueira-Filho et al in 2010 a prognostic classification 
system identifying possible risk factors in patients prior to initiating implant therapy may 
reduce the prevalence of peri-implant mucositis. It can be recommended that future 
research should focus on this. 
 
 
 
 
 
 
 
Page | 53  
 
 
REFERENCES 
 
 
Alissa, R. and Oliver, R., 2011. Influence of prognostic risk indicators on osseo-integrated 
dental implant failure: a matched case-control analysis. Journal of Oral Implantology, 1 – 31. 
 
Atassi, F., 2002. Periimplant probing: positives and negatives. Implant Dentistry, 11, 356 – 
362. 
 
Atieh M.A., Alsabeeha N.H.M., Faffion C.M. and Duncan W.J., 2012. The frequency of peri-
implant diseases: a systematic review and meta-analysis. Journal of Periodontology, 1 – 8. 
 
Barendregt, D.S., Van der Velden, U., Timmerman, M.F. and Van der Weijden, G.A., 2006. 
Comparison of two automated periodontal probes and two probes with a conventional 
readout in periodontal maintenance patients. Journal of Clinical Periodontology, 33, 276 – 
282. 
 
Bayne, S.C., Beck, M., Blue, C., Bowen, D.M., Calley, K.H., Collins, M.A., Connolly, I.M., 
Davison, J.A., Dean, M., Fried, J.L., Gurenlian, J.R., Harper, L.F., Haveles, E.B., Hlava, G.L., 
Ibsen, O.A.C., Nield-Gehrig, J.S., Palmer, D.M., Powers, J.M., Ray, L., Ryan, D.L., Savner, M.D., 
Schlei, H.A., Sroda, R.A., Swift, E.J., Thompson, J.Y., Thomson, E.M., Tolle, S.L., Zarkowski, P., 
Zayan, M.H., 2006. Mosby’s Comprehensive Review of Dental Hygiene. Sixth Edition. Mosby 
Elsevier: Saint Louis. 
 
Bergenholtz, A., Al-Harbi, N., Al-Hummayani, F.M., Anton, P., and Al-Kahtani, S., 2000. The 
accuracy of the Vivacare true pressure-sensitive periodontal probe system in terms of 
probing force. Journal of Clinical Periodontology. 27: 93 – 98. 
 
Chen, S. and Darby, I., 2003. Dental implants: maintenance, care and treatment of peri-
implant infection. Australian Dental Journal, 48 (4), 212 – 220. 
 
Costa F.O., Takenaka-Martinez S., Cota L.O.M., Ferreira S.D., Silva G.L.M. and Costa J.E., 
2012. Peri-implant disease in subjects with and without preventative maintenance: a 5 year 
follow-up. Journal of Clinical Periodontology, 39, 173 – 181.  
 
 
 
 
 
Page | 54  
 
De Brandão, M.L., Vettore, M.V., Vidigal Jὓnior, G.M., 2013. Peri-implant bone loss in 
cement- and screw-retained prostheses: systematic review and meta-analysis. Journal of 
Clinical Periodontology, 40 (3), 287 – 295. 
 
Eickholz, P., Grotkamp, F.L., Steveling, H., Mὓhling, J. and Staehle, H.J., 2001. Reproducibility 
of peri-implant probing force-controlled probe. Clinics of Oral Implants Restorations. 12: 153 
– 158. 
 
Feller L., Khammissa R.A.G., Meyerov R. and Lemmer J., 2012. Peri-implant mucositis and 
peri-implantitis: commentary. SADJ,67 (3), 128 – 129. 
  
Ferreira, S.D., Silva, G.L.M., Cortelli, J.R. and Costa, F.O., 2006. Prevalence and risk variables 
for peri-implant disease in Brazilian subjects. Journal of Clinical Periodontology, 33, 929 – 
935. 
 
Galindo-Moreno, P., Fauri, M., Avila-Ortiz, G., Fernández-Barbero, J.E., Cabrera-León, A. and 
Sánchez-Fernández, E., 2005. Influence of alcohol and tobacco habits on peri-implant 
marginal bone loss: a prospective study. Clinical Oral Implants Research, 16, 579 – 586. 
 
Greenstein, G., Cavallaro, J. and Tarnow, D., 2010. Dental implants in the periodontal 
patients. Dental Clinics of North America, 54, 113 – 128. 
 
Grusovin, M.G., Coulthard, P., Worthington, H.V., George, P. and Esposito, M., 2010. 
Interventions for replacing missing teeth: maintaining and recovering soft tissue health 
around dental implants (review). The Cochrane Collaboration, 12, 1- 40. 
 
Heasman, P., Esmail, Z. and Barclay, C., 2010. Peri-implant diseases. Dental Update, 37, 511 
– 516. 
 
Heitz-Mayfield, L.J.A., 2008. Peri-implant diseases: diagnosis and risk indicators. Journal of 
Clinical Periodontology, 35 (8), 292 – 304. 
 
Liddelow G. and Klineberg I., 2011. Patient-related risk factors for implant therapy. A 
critique of pertinent literature. Australian Dental Journal, 56, 417 – 426. 
 
Karbach, J., Callaway, A., Kwan, Y., d’Hoedt, B. and Al-Nawas, B., 2009. Comparison of five 
parameters as risk factors for peri-mucositis. International Journal of Oral Maxillofacial 
Implants, 24, 491 – 496. 
 
 
 
 
 
Page | 55  
 
Karoussis, I.K., Kotsovilis, S. and Fourmousis, I., 2007. A comprehensive and critical review of 
dental implant prognosis in periodontally compromised partially edentulous patients. 
Clinical Oral Implants Research, 18, 669 – 679. 
 
Khammissa R.A.G., Feller L., Meyerov R. and  Lemmer J., 2012. Peri-implant mucositis and 
peri-implantitis: bacterial infection. SADJ, 67 (2), 70 – 74.  
 
Khammissa R.A.G., Feller L., Meyerov R. and Lemmer J., 2012. Peri-implant mucositis and 
peri-implantitis: clinical and histopathological characteristics and treatment. SADJ, 67 (3), 
122 – 126. 
 
Lindhe, J., Lang, N.P. and Karring, T., 2008. Clinical Periodontology and Implant Dentistry. 
Fifth Edition. Blackwell Munksgaard: Oxford. 
 
Lindhe, J. and Meyle, J., 2008. Peri-implant diseases: consensus report of the sixth European 
workshop on periodontology. Journal of Clinical Periodontology, 35 (8), 282 – 285. 
 
Linkevicius, T., Vindasiute, E., Puisys, A. and Peciuliene, V., 2011. The influence of margin 
location on the amount of undetected cement excess after delivery of cement-retained 
implant restorations. Clinical Oral Implants Research, xx, 1 – 6. 
 
Nissan, J., Narobai, D., Gross, O., Ghelfan, O., and Chaushu, G., 2011. Long-term outcome of 
cemented versus screw-retained implant-supported partial restorations. International 
Journal of Oral and Maxillofacial Implants, 26(5), 1102 – 1107. 
 
Nogueira-Filho, G., Iacopino, A.M. and Tenenbaum, H.C., 2010. Prognosis in implant 
dentistry: a system for classifying the degree of peri-implant mucosal inflammation. Journal 
of Canadian Dental Association, 77, 1 – 6. 
 
Renvert, S. and Persson, G.R., 2009. Periodontitis as a potential risk factor for peri-
implantitis. Journal of Clinical Periodontology, 36 (10), 9 – 14. 
 
Renvert, S., Roos-Jansåker, A.M. and Claffey, N., 2008. Non-surgical treatment of peri-
implant mucositis and peri-implantitis: a literature review. Journal of Clinical 
Periodontology, 35 (8), 305 – 315. 
 
Rinke S., Ohl S., Ziebolz D., Lange K., and Eickholz P, 2011. Prevalence of peri-implant disease 
in partially edentulous patients: a practice-based cross-sectional study. Clinical Oral 
Implants Research, 22, 826 – 833. 
 
 
 
 
Page | 56  
 
 
Rutala WA and Weber DJ, 2004. Disinfection and sterilization in health care facilities: what 
clinicians need to know. Clinical Infectious Diseases. 39: 702 – 709. 
 
Serino, G. and Ström, C., 2008. Peri-implantitis in partially edentulous patients: association 
with inadequate plaque control. Clinical Oral Implants Research, 20, 169 – 174. 
 
Shumaker, N.D., Metcalf, B.T., Toscano, N.T. and Holtzclaw, D.J., 2009. Periodontal and peri-
implant maintenance: a critical factor in long-term treatment success. Compendium, 30 (7), 
388 – 407. 
 
Silva-Herzog, D., Ramirez, T., Mora, J., Pozos, A.J., Silva, L.A., Silva, R.A., and Nelson-Filho, P., 
2011. Preliminary study of the inflammatory response to subcutaneous implantation of 
three root canal sealers. International Endodontics Journal, 44(5), 440 -446. 
 
Strietzel, F.P., Reichart, P.A., Kale, A., Kulkarni, M., Wegner, B. and Kűchler, I., 2007. Smoking 
interferes with the prognosis of dental implant treatment: a systematic review and meta-
analysis. Journal of Clinical Periodontology, 34, 523 – 544. 
 
Thὃne-Mühling, M., Swierkot, K., Nonnenmacker, C., Mutters, R., Flores-de-Jacoby, L. and 
Mengel, R., 2010. Comparison of two full-mouth approaches in the treatment of peri-
implant mucositis: a pilot study. Clinical Oral Implantology, 21, 504 – 512. 
 
Vigolo, P., Mutinelli, S., Givani, A., and Stellini, E., 2012. Cemented versus screw-retained 
implant-supported single-tooth crowns: a 10-year randomised controlled trial. European 
Journal of Oral Implantology, 5 (4), 355 – 364. 
 
Zupnik, J.T., Kim, S., Ravens, D.P., Karimbux, N.Y. and Guze, K.A., 2011. Factors associated 
with dental implant survival: a four-year retrospective analysis. Journal of Periodontology, 
ahead of print, 1 – 9. 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 57  
 
 
APPENDICS 1: 
Data Collection Form 
 
 
 
 
 
 
 
 
Page | 58  
 
 
APPENDICS 2: 
Consent Form 
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APPENDICS 3: 
Patient Information Letter 
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APPENDICS 4: 
Patient Consent to Clinical Photography and Video Recording 
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APPENDICS 5: 
Approval by Ethics Committee 
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APPENDICS 6: 
Diary of Researcher 
 
 
 January 2011 and February 2011: 
 
Conceptualising research topic and starting with literature review. 
 
 March 2011: 
 
Submission of literature review in order to complete the research methodology module. 
 
 August 2011: 
 
Submission of methodology section in order to complete the research methodology 
module. 
 
 November 2011: 
 
Protocol presentation and submission to complete research methodology module. 
 
 December 2011: 
 
Submit protocol for ethics approval by the Research and Ethics Committee of the University 
of the Western Cape. 
 
 March 2012: 
 
Obtain ethical clearance from the Research and Ethics Committee of the University of the 
Western Cape. Project registration number is 12/1/19. 
 
 April 2012: 
 
Primary researcher calibration as well as calibration of Vivacare TPS probe completed. 
Initiating study and start with data collection. 
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 July 2012: 
 
Meeting with co-supervisor of mini-thesis to discuss slow progression of data collection: 
could only manage to evaluate 26 patients. Decide to offer patients a free cleaning after 
examination for data collection as incentive to come for follow-up. Agree on cut-off date for 
data collection: November 2012. 
 
 November 2012: 
 
Data collection completed on 19 November 2012. Study population is 74 patients. Arrange 
first meeting with statistician for data analysis. 
 
 December 2012: 
 
Final meeting with statistician on 19 December 2012 and statistical analysis completed. 
 
 January to June 2013: 
 
Writing of mini-thesis and submission to supervisor and co-supervisor for corrections. 
 
 July to August 2013: 
 
Submission of mini-thesis for evaluation by the external examiners. 
 
 
 
 
 
 
